Mesoblast (MESO) Other Working Capital Changes (2016 - 2025)
Mesoblast's (MESO) quarterly Other Working Capital Changes came in at -$1.7 million in Q4 2025, down 45.41% year-on-year from -$3.2 million in Q4 2024, and down 45.41% quarter-over-quarter from -$1.2 million in Q2 2025.
Mesoblast (MESO) Other Working Capital Changes (2016 - 2025) Analysis & Trends
Mesoblast has disclosed Other Working Capital Changes across 10 years of filings, most recently posting -$1.7 million for Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$1.7 million, down 45.41% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.3 million (down 126.59% YoY), and the FY2025 annual result was -$1.2 million, down 814.5% from the prior year.
- Other Working Capital Changes came in at -$1.7 million for Q4 2025 at Mesoblast, down from -$1.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.4 million in Q1 2022 to a low of -$2.2 million in Q1 2021.
- The 5-year median for Other Working Capital Changes is -$424000.0 (2022), against an average of -$232066.7.
- Across the five-year window, Other Working Capital Changes surged 207.02% in 2022 and plunged 814.5% in 2024, its largest moves.
- Mesoblast's Other Working Capital Changes stood at -$1.5 million in 2021, then surged by 71.56% to -$424000.0 in 2022, then jumped by 69.1% to -$131000.0 in 2023, then slumped by 814.5% to -$1.2 million in 2024, then tumbled by 45.41% to -$1.7 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.7 million (Q4 2025), -$1.2 million (Q2 2025), and -$1.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.74 Mn |
| Dec 31, 2025 | -1.74 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Jun 30, 2024 | -131,000.00 |
| Jun 30, 2024 | -131,000.00 |
| Dec 31, 2023 | -131,000.00 |
| Dec 31, 2023 | -131,000.00 |
| Jun 30, 2023 | -424,000.00 |
| Jun 30, 2023 | -424,000.00 |
| Mar 31, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | -424,000.00 |
| Dec 31, 2022 | -424,000.00 |
| Sep 30, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 901,000.00 |
| Jun 30, 2022 | 901,000.00 |